.
 Shital Kamble.
 https://www.facebook.com/shital.kamble.735
 https://www.linkedin.com/pub/shital-kamble/5/98/a8b

Started Working at Bristol-Myers Squibb

Princeton, New Jersey

 

Shital Kamble

Associate Director at BMS

Summary

Health Outcomes Research, Prospective observational study Design and Analysis, Health Economics, Trial-based and Model-based Economic Evaluation, Clinical Trial Design, Studies involving Secondary Database Analyses, Biostatistics, Late Phase Studies

Specialties:health economics and outcomes research, study design and analyses, biostatistics, patient-reported outcomes, health services research, market research, product management

Experience

Associate Director, CV

Bristol-Myers Squibb

November 2014 – Present (11 months)

Senior Outcomes Research Manager

Quintiles

November 2012 – October 2014 (2 years)rockville, maryland

Outcomes Research Manager

Quintiles

March 2011 – October 2012 (1 year 8 months)

Research Fellow- HEOR

Duke Clinical Research Institute

August 2009 – March 2011 (1 year 8 months)

Graduate Student - Research Fellow

Univ. of North Carolina at Charlotte

August 2006 – August 2009 (3 years 1 month)

Graduate Student Instructor

University of the Sciences in Philadelphia

January 2004 – December 2004 (1 year)

Product Specialist

Shantha Biotechnics Limited,Part of Sanofi Aventis Group

July 2002 – September 2003 (1 year 3 months)Mumbai Area, India

Promoted biosimilars in entire Mumbai region, India (Gastroenterology and Oncology).

Education

University of North Carolina at Charlotte

Ph.D., Health Services Research

2005 – 2009

Activities and Societies: Active member - ISPOR and Graduate Public Health Association at the University of North Carolina at Charlotte Invited member - The Honor Society of Phi Kappa Phi and Phi Beta Delta- Honor Society for International Scholars, Mu Chapter: The University of North Carolina at Charlotte Member- AcademyHealth, American Heart Association, and North Carolina Public Health Association.

University of the Sciences in Philadelphia

M.S., Pharmacy Administration

2003 – 2004

Activities and Societies: Member- ISPOR President- ISPOR Student Chapter at the University of the Sciences in Philadelphia

Jankidevi Bajaj Institute of Management Studies

MBA, Marketing

2000 – 2002

University Institute of Chemical Technology (UICT)

B.Pharm, Pharmacy, Pharmaceutical Sciences

1996 – 2000

Thomas Jefferson University

At Shital and Harshal's beautiful home in Skillman, NJ.

 



 
///////

Dr. Muppala Raju

Dr.​​Muppala S. Raju
Vice President, Chemistry

DavosPharma Tech Ops Team

davo79.wix.com
msraju@davos.com

A Leading Provider of Discovery, Chemistry and Formulation Services

Dr. Muppala Raju joined DavosPharma in 1995. He is responsible for the development of DavosPharma' business activities in India.

Dr. Muppala Raju joined DavosPharma in 1995. He is responsible for the development of DavosPharma' business activities in India. Dr. Raju is also head of chemistry atDavosPharma where he directs the process development of all contracted projects at DavosPharma' worldwide custom manufacturers.

Prior to joining DavosPharma, Dr. Raju held several positions including Manager of Chemical Process R&D for Celgene Corporation. He was also a Research Scientist for Rhône-Poulenc Research Center, Research Chemist for PPG Industries and held post doctoral positions at the University of Iowa and Rockefeller University.

Dr. Raju has co-authored fifteen research publications and has been issued six patents.

He holds a Ph.D. from Rice University and an MBA from Kent State University.

Employment History

• Vice President, Chemistry, Davos Chemical Corporation

• Head of Chemistry, Davos Chemical Corporation

• Manager of Chemical Process Research and Development, Celgene Corporation

• Post Doctoral Positions, Rockefeller University

• Post Doctoral Positions, University of Iowa

• Research Scientist, Rhône-Poulenc Research Center

Education

• MBA, Kent State University

• Ph.D., Rice University

Barry Robins. President. Davos Pharma
Davos Chemical Corporation provides chemistry and pharmaceutical services for biotechs and pharmaceutical companies in United States, Europe, and Asia. The company offers drug substance and drug products in the areas of preclinical/clinical supply, commercial manufacture, and cytotoxics and other compounds; documentation preparation and support services; oral and parenteral clinical trial materials; synthesized materials, including APIs and intermediates; analytical services, such as methods development, testing, and validation; preformulation and formulation development services; chemistry development and optimization services; and medicinal chemistry and biology discovery services.

600 East Crescent AvenueUpper Saddle RiverNew Jersey07458United States

View Map

(201) 995-0070(201) 995-0071Fax

www.davos.com

http://www.davos.com/about/davos_techops.html

DavosPharma Technical Operations Team

//////